Integra holds revenue forecast at $1.634–1.654 billion as flood fallout persists

Key Facts

Integra LifeSciences reaffirmed its 2026 revenue forecast of $1.634 billion to $1.654 billion in its earnings release on October 21, as the fallout from flooding at its Cincinnati facility continued. The medical technology company maintained the estimates announced after it cut its outlook in an October 2 preliminary results update. Its previous annual revenue range was $1.654 billion to $1.695 billion, before incorporating the impact of flood-related supply disruptions. The reaffirmed outlook comes as the company deals with damage to the facility, production equipment and inventory that disrupted operations. The estimates cover the current fiscal year, including the months following the July flood. The company had announced the lower revenue range and the facility's recovery timeline before releasing its final quarterly results.

Integra's third-quarter 2026 results showed revenue rose to $411.2 million, according to the company's statement, representing reported growth of 2.3% from the same period a year earlier. Adjusted diluted earnings per share also rose to $0.59 from $0.54 in the third quarter of 2025. The company thus recorded year-on-year increases in both revenue and adjusted earnings per share during the quarter in which the flood occurred. On cash generation, cash flows from operating activities totaled $96.0 million in the third quarter. These cash flows came as the company continued to address the operational disruption at its Cincinnati site. The results were announced before the facility's return to full manufacturing operations, which the company expects next year.

By business, the specialty surgical segment accounted for the bulk of quarterly revenue, generating $304.1 million, according to the earnings statement. Tissue reconstruction revenue totaled $107.1 million in the third quarter of 2026. Integra's medical technology portfolio focuses on neurosurgery and tissue reconstruction, according to the company's description of its business in its bond pricing statement. Specialty surgical revenue forms part of the company's broader surgical products business, alongside its tissue reconstruction operations. The Cincinnati disruption involves a manufacturing site within the company's operations, after flooding damaged parts of the facility and its assets. Integra continues to report results for both segments as the process of restoring full operations at the damaged site extends beyond the end of the current fiscal year.

The disruption stems from flooding in July 2026 that damaged the building, equipment, inventory and other assets in Cincinnati, according to the company's preliminary results update. The incident disrupted operations and supplies, in addition to causing physical damage to assets at the site. Integra said it has property and business interruption insurance coverage for the affected facility. The company expects insurance proceeds to offset "a substantial portion" of the disruption's earnings impact, according to the wording in its statement. The expected compensation relates to the recovery period through the return to full manufacturing capacity, including the earnings impact while operations are restored. The company's compensation expectations are based on its property damage and business interruption coverage, as it continues to address the flood's consequences at the production site.

Alongside its operational recovery, Integra completed refinancing transactions in October 2026 that included a bond issue and an amendment to its credit facility, according to a separate company statement. It closed an offering of secured notes with an aggregate principal amount of $450.0 million and an interest rate of 9.500%. The notes mature in 2033, according to the terms the company announced upon completing the transactions. Integra also amended and restated its credit facility, with a total size of approximately $1.65 billion. It used proceeds from the notes offering, together with borrowings under the facility, to refinance existing credit and pay related fees and expenses. The refinancing transaction thus combined borrowing through secured notes and the amended credit facility, with proceeds directed toward existing obligations and transaction completion costs.

For the fourth quarter of 2026, Integra expects revenue of $413 million to $433 million, according to the guidance in its earnings statement. In its October 2 update, the company had estimated that flood-related supply disruptions would reduce revenue for the quarter by about $15–20 million. The expected impact extends the incident's fallout into the period following the reported third-quarter results. The company expects the Cincinnati facility to return to full manufacturing operations during the second quarter of 2027. That timeline had already been included in the early October update, alongside the reduction in annual revenue guidance and the estimate of upcoming supply-related losses. Until full capacity is restored, Integra expects insurance proceeds to continue offsetting a substantial portion of the disruption's earnings impact during the recovery period.